# Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel

> **NCT03562091** · — · COMPLETED · sponsor: **Ipsen** · enrollment: 115 (actual)

## Conditions studied

- Neuroendocrine Tumors

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT03562091
- **Lead sponsor:** Ipsen
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-20
- **Primary completion:** 2020-05-15
- **Final completion:** 2020-05-15
- **Target enrollment:** 115 (ACTUAL)
- **Last updated:** 2020-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03562091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03562091, "Perception of Information and Quality of Life in Neuroendocrine Tumour on Lanreotide Autogel". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT03562091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*